Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings
Co-Diagnostics, Inc. reported Q1 2025 revenue of $50.3K (-80.1% YoY), missed analyst consensus of $187.5K by $137.2K. Diluted EPS came in at $-0.24 (+22.6% YoY), beat the $-0.33 consensus by $0.09.
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Co-Diagnostics, Inc. 's Q1 2025 earnings report.
Co-Diagnostics, Inc. (CODX) reported Q1 2025 earnings on May 8, 2025 after market close.
Co-Diagnostics, Inc. reported revenue of $50.3K and diluted EPS of $-0.24 for Q1 2025.
Revenue missed the consensus estimate of $187.5K by $137.2K. EPS beat the consensus estimate of $-0.33 by $0.09.
Compared to the same quarter a year prior, revenue declined 80.1% from $252.7K a year earlier and diluted EPS grew 22.6% from $-0.31.
You can read the 10-Q periodic report (0001641172-25-009257) directly on SEC EDGAR. The filing index links above go to sec.gov.